How to respond to Covid19 pandemic in West and Central Africa
Protecting Migrants or Reversing Migration? COVID-19 and the risks of a protracted crisis in Latin America
The WHO COVID-19 Essential Supplies Forecasting Tool (COVID-19-ESFT) is meant to help countries forecast essential supplies for their COVID-19 response including personal protective equipment (e.g., masks and gloves), biomedical equipment for case management (e.g., ventilators and oxygen concentrato
...
rs), diagnostic reagents and equipment, essential drugs for supportive care, and consumable medical supplies.
The tool is best suited for estimating essential supply needs over a short time period (12 weeks or fewer) but can be used for longer.
COVID-19-ESFT does not quantify or account for resources already available locally or those pending delivery. When using the ESFT to inform procurement, we recommend factoring in resources already available locally and only including the additional resources required in the forecast.
This tool is updated regularly so users should monitor the website for the latest release version.
more
Эпиднадзор за состоянием окружающей среды посредством исследования сточных вод на наличие патогенных микроорганизмов давно применяется в общественном здравоох
...
анении, в частности, в связи с полиовирусом,
а с недавнего времени — также в связи с проблемой устойчивости к противомикробным препаратам (УПП) . В условиях
нынешней пандемии COVID-19 данная методика используется для определения в сточных водах вируса SARS-CoV-2,
выделяемого через верхние отделы желудочно-кишечного тракта и верхние дыхательные пути, а также с фекалиями.
disease control SARS-CoV-2
more
В этом документе представлены технические подробности и методологические пояснения по структуре инструмента ВОЗ
для прогнозирования запасов основных материало
...
в для работы с COVID-19 (ESFT). Документ предназначен для
предоставления информации, которая позволит пользователям a) отслеживать и понимать расчеты, допущения и
ограничения ESFT; и b) изменять эти допущения для различных условий или вариантов использования.
Таблица Excel см. ESFT
more
В этом документе изложена стратегия
Европейского региона ВОЗ в области
реагирования на COVID-19 и ликвидации
его последствий на основе актуальной
глобальной страт
...
гии ВОЗ в сфере борьбы
с COVID-19 на период с февраля по декабрь 2020 г.
more
В настоящей Системе ценностей изложены рекомендации
глобального масштаба по распределению вакцин против
COVID-19 между странами, а также рекомендации
национальног
...
о уровня по определению приоритетности
групп для получения вакцинации внутри стран в условиях
ограниченных поставок. Система ценностей будет полезна
политикам и экспертам-консультантам на глобальном,
региональном и национальном уровнях при принятии
решений о распределении вакцин против COVID-19 и
определении приоритетности их получения.
more
Indonesia, Malaysia, Myanmar, and Pakistan
Spetember 2020
MEDBOX Issue Brief no.9 ,1 Febr. 2021
Evolving Patterns of Worldwide Distribution as of 14thFebruary 2021
This strategic document is relevant to the diverse contexts that exist across the WHO European Region, and to countries implementing a wide range of national and subnational responses. The strategy is flexible and adaptable to national and subnational contexts and guides countries in rapidly bringin
...
g COVID-19 cases under control, and in preparing for a phased transition from a widespread transmission to a steady state of low-level or no transmission.
more
Community health workers (CHWs) play a vital role in health service delivery, especially in countries with less resilient health systems. During any outbreak CHWs are relied on to help control the spread. However, they are often the last in line to receive necessary health products and protective eq
...
uipment, which affects their ability to safely serve their communities.
more
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch
...
ildren. If children with mild or no symptoms transmit the disease, they may act as drivers of transmission within their communities. Understanding symptoms, infectivity and patterns of SARS-CoV-2 transmission in children and adolescents is essential for developing, adapting and improving control measures for COVID-19 across all ages. This is a summary of the current knowledge around SARS-CoV-2 infection acquisition and transmission and COVID-19 disease symptoms in children and adolescents. It aims to inform decisions, based on local contexts, on how to best keep schools, kindergarten and day-care facilities open and what advice to apply to intergenerational mixing.
more
WHO has developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings. This first version was developed by patients, researchers and others, representing all WHO regions, with the understanding that the definition ma
...
y change as new evidence emerges and our understanding of the consequences of COVID-19 continues to evolve.
Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms and that last for at least 2 months and cannot be explained by an alternative diagnosis. Common symptoms include fatigue, shortness of breath, cognitive dysfunction but also others and generally have an impact on everyday functioning. Symptoms may be new onset following initial recovery from an acute COVID-19 episode or persist from the initial illness. Symptoms may also fluctuate or relapse over time.
more
To assess the impact of the COVID-19 pandemic on health and HIV expenditure, UNAIDS carried out a modelling study on fiscal space for health and HIV. From a sample of 28 countries, three countries—the Democratic Republic of the Congo, Jamaica, and Lesotho—were selected to capture health and HIV
...
expenditure impacts across countries with especially marked differences in burdens of disease (including HIV prevalence), HIV donor dependency, level of economic development, and geographic location. While the three-country sample is too small to permit findings to be generalized to other countries, these analyses are useful for informing UNAIDS’ work to identify some policy positions to minimize the COVID-19 pandemic’s impact on the HIV response.
more
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
ve role in restricting fair access to a life-saving health product. This report focuses on six leading vaccine developers, AstraZeneca, BioNTech, Johnson & Johnson, Moderna, Novavax and Pfizer, assessing each company’s human rights policy, pricing structure, records on intellectual property, knowledge and technology sharing, allocation of available vaccine doses and transparency.
Available in Arabic, English, French, German and Spanish
more